Kymera | IPO Presentation Deck | 49 slides · page 24 of 49
The slide demonstrates a dose-dependent response of KT-474 in a disease model, linking target degradation (IRAK4) to phenotypic outcomes.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 5/5
chart 2/2 paragraph 1/1 table 1/1 title 1/1
Components 5
bar-vertical bar-vertical paragraph data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.